MedPath

Functional Imaging and Reading Deficit in Children With NF1

Not Applicable
Completed
Conditions
Neurofibromatosis Type 1
Interventions
Other: Neuropsychological assessments
Radiation: morphological and functional MRI (fMRI)
Genetic: genetic analysis
Registration Number
NCT02422732
Lead Sponsor
University Hospital, Toulouse
Brief Summary

A monocenter pilot study on the acceptability and feasibility of a functional MRI protocol in children with NF1 with or without reading disabilities.

Detailed Description

The principal aim of the study is to highlight the activation of brain area involved phonological and visuo-spatial processing in children with NF1 with or without reading disabilities.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Age included between 8 and 12 years

  • Child presenting a type 1 neurofibromatosis according to 2 criteria in the following criteria list :

    • At least 6 café au lait spots
    • 2 or more neurofibromas or 1 plexiform neurofibroma
    • axillary or inguinal freckling
    • 1 optic nerf glioma
    • 2 or more Lisch nodules
    • 1 osseous lesion as sphenoid dysplasia or thinning of the long bone cortex with or without pseudarthrosis
    • 1 A first degree relative (parent, sibling, or offspring) with NF1 by the above criteria
  • Membership in a national insurance

  • Consent of the child and the parents

Exclusion Criteria
  • Mental retardation (QI T < 70)
  • Treated or untreated epilepsy
  • Visual deficit (visual Acuteness < 4/10
  • Presence of a symptomatic optic glioma
  • Presence of a brain tumor.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Children with reading disabilitygenetic analysisChildren with NF1, with reading disability if their performances on reading assessment (Alouette Test) present a delay of at least 18 months, will have Neuropsychological assessments, morphological and functional MRI (fMRI) and genetic analysis
Children without reading disabilityNeuropsychological assessmentsChildren with NF1, without reading disability if their performances on reading assessment (Alouette Test) present a less than 18-month delay, will have Neuropsychological assessments, morphological and functional MRI (fMRI) and genetic analysis.
Children without reading disabilitymorphological and functional MRI (fMRI)Children with NF1, without reading disability if their performances on reading assessment (Alouette Test) present a less than 18-month delay, will have Neuropsychological assessments, morphological and functional MRI (fMRI) and genetic analysis.
Children with reading disabilitymorphological and functional MRI (fMRI)Children with NF1, with reading disability if their performances on reading assessment (Alouette Test) present a delay of at least 18 months, will have Neuropsychological assessments, morphological and functional MRI (fMRI) and genetic analysis
Children without reading disabilitygenetic analysisChildren with NF1, without reading disability if their performances on reading assessment (Alouette Test) present a less than 18-month delay, will have Neuropsychological assessments, morphological and functional MRI (fMRI) and genetic analysis.
Children with reading disabilityNeuropsychological assessmentsChildren with NF1, with reading disability if their performances on reading assessment (Alouette Test) present a delay of at least 18 months, will have Neuropsychological assessments, morphological and functional MRI (fMRI) and genetic analysis
Primary Outcome Measures
NameTimeMethod
Percentage of children performing in full the protocol functional MRIday 1

Study the acceptability and feasibility of a functional MRI protocol in children with NF1 with or without reading disabilities.

Secondary Outcome Measures
NameTimeMethod
blood flow in milliliters per minuteday 1

Comparison of brain activations involved in phonological and visuo-spatial processing in 2 groups in children with NF1.

1 group with reading disability and 1 group without reading disability Search for a link between the presence of a large deletion of the gene and learning disorders.

Trial Locations

Locations (1)

CHU Toulouse

🇫🇷

Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath